Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
In this study the investigators are comparing this standard regimen to the newly established regimen of melphalan and bortezomib.
Epistemonikos ID: 8df58aa6a82f237bf47be955afafe40942a5eb0d
First added on: May 10, 2024